Napredna pretraga

Pregled bibliografske jedinice broj: 485183

A recombinant bivalent protein that links innate and adoptive immune mechanisms might serve in the treatment of viral infection


Šmurinić, Maja; Lenac Roviš, Tihana; Zurunić, Antonija; Jonjić, Stipan
A recombinant bivalent protein that links innate and adoptive immune mechanisms might serve in the treatment of viral infection // 2010 Annual Meeting of the Croatian Immunological Society, book of abstracts / Rabatić, Sabina (ur.).
Mali Lošinj, Hrvatska, 2010. str. 48-48 (poster, domaća recenzija, sažetak, znanstveni)


Naslov
A recombinant bivalent protein that links innate and adoptive immune mechanisms might serve in the treatment of viral infection

Autori
Šmurinić, Maja ; Lenac Roviš, Tihana ; Zurunić, Antonija ; Jonjić, Stipan

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
2010 Annual Meeting of the Croatian Immunological Society, book of abstracts / Rabatić, Sabina - , 2010, 48-48

Skup
2010 Annual Meeting of the Croatian Immunological Society

Mjesto i datum
Mali Lošinj, Hrvatska, 23-26.09.2010

Vrsta sudjelovanja
Poster

Vrsta recenzije
Domaća recenzija

Ključne riječi
Recombinant protein; monoclonal antibody; viral infection

Sažetak
HCMV is an important human pathogen in immunocompromised and immunologically immature individuals. Up to 75% of patients undergoing solid organ transplantation suffer from the primary infection or reactivation of latent HCMV infection despite the use of prophylactic and preemptive antiviral therapy. Therefore, a recombinant fusion protein has been developed and is being tested in the MCMV infection therapy model. Like many other herpesviruses, CMV possesses numerous mechanisms aimed at avoiding or compromising the host's immune response, among others, downregulation of ligands for the activating NK cell receptor NKG2D. The developed protein's therapeutic potential lies in its ability to bypass the components of innate and specific immune responses. The protein is composed of the ectodomain of a high affinity ligand for the NKG2D receptor, MULT-1, and variable regions of the immunoglobulin specific for the viral protein expressed on the surface of infected cells, gB. It is expected that such molecule, when applied in vivo, can mediate a specific activation of NK cells leading to the control of viral infection.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija



POVEZANOST RADA


Ustanove
Medicinski fakultet, Rijeka